Why are we talking about access and benefit-sharing?
The entry into force of the Convention on Biological Diversity (CBD) in 1993 marks a fundamental shift in how genetic resources are considered by the international community. Prior to the CBD, free access to genetic resources had prevailed. However, developments in biotechnology since the mid-1970s made the search for new and unforeseen uses for genetic resources possible.
This attracted greater attention to the value of these resources. Like many other resources in the world, genetic resources are not evenly distributed. In the early 1980s, several countries started restricting access to the genetic resources under their jurisdiction and calling for increased control over their genetic resources 1 .
During the negotiations of the CBD, many developing countries wanted the value and contribution of genetic resources to be recognised and the benefits resulting from their use to be shared more fairly and equitably. The fair and equitable sharing of benefits arising out of the utilisation of genetic resources came to be one of the three objectives of the CBD, together with the conservation of biological diversity, and the sustainable use of its components. The concept aimed at re-directing benefit flows back to countries providing genetic resources, while creating incentives for the conservation and sustainable use of biological diversity.
What are the access and benefit-sharing principles of the CBD?
The CBD established the concept of access and benefit-sharing (ABS), which refers to how genetic resources may be accessed, and how the benefits resulting from their use are shared between the people, institutions or countries using the resources (users) and the people or countries that provide them (providers) 2 .
Using genetic resources, whether from plants, animals or microorganisms, refers to the process of researching their beneficial properties and using them to increase scientific knowledge and understanding, or to develop commercial products. Users of genetic resources are required to obtain permission, the prior informed consent (PIC), of the country providing access to the genetic resource and negotiating and agreeing on the terms and conditions of access and utilisation of this resource through the establishment of mutually agreed terms (MAT). This agreement is also to address the sharing of benefits arising from the utilisation of the resource. maximises the benefits for users, providers and the communities where those resources are found.
In 2010, the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilisation was adopted as a supplementary agreement to the Convention to advance its third objective, building on the provisions of the CBD.
The Nagoya Protocol establishes an international, legally binding framework to promote the transparent and effective implementation of access and benefit-sharing at the national level. The Protocol helps establishing more predictable conditions for access to genetic resources while also helping to ensure benefit-sharing when genetic resources leave the country providing the genetic resources. Thus, the Nagoya Protocol helps to create trust between users and providers of genetic resources by providing a clear transparent framework for access and benefit-sharing and further legal certainty.
The Nagoya Protocol entered into force in October 2014, after ratification by 50 countries. As of 9 July 2019, 119 Parties [once a country ratifies an intergovernmental treaty, they become a Party to the treaty] to the CBD had ratified the Protocol (Figure 1 
What does the Nagoya Protocol provide for?
The Nagoya Protocol covers genetic resources, including microorganisms, plants, and animals, as well as traditional knowledge associated with genetic resources. It sets out a new regime with core obligations for its contracting Parties to take measures in relation to access, benefit-sharing and compliance. The In Focus including through the application of biotechnology as defined in Article 2 of the Convention' 4 .
Benefit-sharing
Under the Nagoya Protocol, benefits arising from the utilisation of genetic resources as well as subsequent applications and commercialisation are to be shared in a fair and equitable way with the provider country. This sharing is upon mutually agreed terms. 
ABS Clearing-House
The Nagoya Protocol establishes the ABS Clearing-House as a platform for exchanging information on ABS 5 
How does the Nagoya Protocol address non-commercial research?
During the negotiations of the Nagoya Protocol, the scientific community expressed concerns about the impact that ABS provisions could have on non-commercial research. The Protocol requires Parties to create conditions to promote and encourage research that contributes to the first and second objective of the CBDthat is conservation and sustainable use of biological diversity 6 .
What does the Nagoya Protocol mean for users of genetic resources?
The Nagoya Protocol, in order to be operational, must be 
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